Expression of a dominant negative CELF protein in vivo leads to altered muscle organization, fiber size, and subtype
- PMID: 21541285
- PMCID: PMC3082560
- DOI: 10.1371/journal.pone.0019274
Expression of a dominant negative CELF protein in vivo leads to altered muscle organization, fiber size, and subtype
Abstract
Background: CUG-BP and ETR-3-like factor (CELF) proteins regulate tissue- and developmental stage-specific alternative splicing in striated muscle. We previously demonstrated that heart muscle-specific expression of a nuclear dominant negative CELF protein in transgenic mice (MHC-CELFΔ) effectively disrupts endogenous CELF activity in the heart in vivo, resulting in impaired cardiac function. In this study, transgenic mice that express the dominant negative protein under a skeletal muscle-specific promoter (Myo-CELFΔ) were generated to investigate the role of CELF-mediated alternative splicing programs in normal skeletal muscle.
Methodology/principal findings: Myo-CELFΔ mice exhibit modest changes in CELF-mediated alternative splicing in skeletal muscle, accompanied by a reduction of endomysial and perimysial spaces, an increase in fiber size variability, and an increase in slow twitch muscle fibers. Weight gain and mean body weight, total number of muscle fibers, and overall muscle strength were not affected.
Conclusions/significance: Although these findings demonstrate that CELF activity contributes to the normal alternative splicing of a subset of muscle transcripts in vivo, the mildness of the effects in Myo-CELFΔ muscles compared to those in MHC-CELFΔ hearts suggests CELF activity may be less determinative for alternative splicing in skeletal muscle than in heart muscle. Nonetheless, even these small changes in CELF-mediated splicing regulation were sufficient to alter muscle organization and muscle fiber properties affected in myotonic dystrophy. This lends further evidence to the hypothesis that dysregulation of CELF-mediated alternative splicing programs may be responsible for the disruption of these properties during muscle pathogenesis.
Conflict of interest statement
Figures






Similar articles
-
Gene expression analyses implicate an alternative splicing program in regulating contractile gene expression and serum response factor activity in mice.PLoS One. 2013;8(2):e56590. doi: 10.1371/journal.pone.0056590. Epub 2013 Feb 20. PLoS One. 2013. PMID: 23437181 Free PMC article.
-
CELF-mediated alternative splicing is required for cardiac function during early, but not later, postnatal life.J Mol Cell Cardiol. 2009 Mar;46(3):395-404. doi: 10.1016/j.yjmcc.2008.10.030. Epub 2008 Nov 24. J Mol Cell Cardiol. 2009. PMID: 19073192
-
Gene Expression Analyses during Spontaneous Reversal of Cardiomyopathy in Mice with Repressed Nuclear CUG-BP, Elav-Like Family (CELF) Activity in Heart Muscle.PLoS One. 2015 Apr 20;10(4):e0124462. doi: 10.1371/journal.pone.0124462. eCollection 2015. PLoS One. 2015. PMID: 25894229 Free PMC article.
-
CUG-BP, Elav-like family (CELF)-mediated alternative splicing regulation in the brain during health and disease.Mol Cell Neurosci. 2013 Sep;56:456-64. doi: 10.1016/j.mcn.2012.12.003. Epub 2012 Dec 14. Mol Cell Neurosci. 2013. PMID: 23247071 Free PMC article. Review.
-
The Muscleblind family of proteins: an emerging class of regulators of developmentally programmed alternative splicing.Differentiation. 2006 Mar;74(2-3):65-80. doi: 10.1111/j.1432-0436.2006.00060.x. Differentiation. 2006. PMID: 16533306 Review.
Cited by
-
The importance of CELF control: molecular and biological roles of the CUG-BP, Elav-like family of RNA-binding proteins.Wiley Interdiscip Rev RNA. 2012 Jan-Feb;3(1):104-21. doi: 10.1002/wrna.107. Epub 2011 Aug 17. Wiley Interdiscip Rev RNA. 2012. PMID: 22180311 Free PMC article. Review.
-
Correction of GSK3β at young age prevents muscle pathology in mice with myotonic dystrophy type 1.FASEB J. 2018 Apr;32(4):2073-2085. doi: 10.1096/fj.201700700R. Epub 2018 Jan 5. FASEB J. 2018. PMID: 29203592 Free PMC article.
-
Correction of RNA-Binding Protein CUGBP1 and GSK3β Signaling as Therapeutic Approach for Congenital and Adult Myotonic Dystrophy Type 1.Int J Mol Sci. 2019 Dec 21;21(1):94. doi: 10.3390/ijms21010094. Int J Mol Sci. 2019. PMID: 31877772 Free PMC article. Review.
-
Evaluating the effects of CELF1 deficiency in a mouse model of RNA toxicity.Hum Mol Genet. 2014 Jan 15;23(2):293-302. doi: 10.1093/hmg/ddt419. Epub 2013 Sep 2. Hum Mol Genet. 2014. PMID: 24001600 Free PMC article.
-
Arrest is a regulator of fiber-specific alternative splicing in the indirect flight muscles of Drosophila.J Cell Biol. 2014 Sep 29;206(7):895-908. doi: 10.1083/jcb.201405058. Epub 2014 Sep 22. J Cell Biol. 2014. PMID: 25246617 Free PMC article.
References
-
- Pan Q, Shai O, Lee LJ, Frey BJ, Blencowe BJ. Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nat Genet. 2008;40(12):1413–1415. - PubMed
-
- Charlet-B N, Logan P, Singh G, Cooper T. Dynamic antagonism between ETR-3 and PTB regulates cell type-specific alternative splicing. Mol Cell. 2002;9:649–658. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials